bosentan anhydrous has been researched along with hydrochloric acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukutomi, H; Goto, K; Hassan, M; Hayashi, T; Iwata, R; Kashimura, H; Matsumaru, K; Muto, H; Nakahara, A; Tanaka, N | 1 |
| Bitzinger, DI; Gruber, M; Ittner, KP; Lubnow, M; Nietsch, R; Pawlik, M; Trabold, B | 1 |
2 other study(ies) available for bosentan anhydrous and hydrochloric acid
| Article | Year |
|---|---|
Bosentan, a novel synthetic mixed-type endothelin receptor antagonist, attenuates acute gastric mucosal lesions induced by indomethacin and HCl in the rat: role of endogenous endothelin-1.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Gastric Mucosa; Hydrochloric Acid; Indomethacin; Male; Rats; Rats, Wistar; Regional Blood Flow; Stomach Ulcer; Sulfonamides; Time Factors | 1997 |
Bosentan reduces oxidative burst in acid aspiration-induced lung injury in rats.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bosentan; Hydrochloric Acid; Male; Neutrophils; Pneumonia, Aspiration; Random Allocation; Rats; Rats, Sprague-Dawley; Respiratory Burst; Sulfonamides | 2009 |